Lyell Immunopharma Inc

NASDAQ:LYEL

2.17

-0.03 (-1.36%)

7:30:32 PM EDT: $2.19 +0.02 (+0.92%)

Lyell Immunopharma Inc Stock, NASDAQ:LYEL

201 Haskins Way, Suite 301, South San Francisco, California 94080

United States of America

Phone: +1.650.695.0677

Number of Employees: 224

http://www.lyell.com

Description

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.